Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis

Critical Care Medicine

Volumn 25, Issue 8, 1997, Pages 1392-1395

  Galley, Helen F ^a   Nelson, Simon J ^a   Dubbels, Anne M ^a   Webster, Nigel R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Antibiotics; Ciprofloxacin; Cytokine; Endothelium; Interleukin 8; Interleukin 6; Nitric oxide; Quinolone; Sepsis

Indexed keywords

CIPROFLOXACIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NITRITE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOTENSION; INFECTION; INFLAMMATION; PRIORITY JOURNAL; SEPSIS; TISSUE INJURY;

ANTI-INFECTIVE AGENTS; CELL LINE; CIPROFLOXACIN; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LUNG NEOPLASMS; NITRITES; SEPSIS; TUMOR CELLS, CULTURED;

EID: 0030802162     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199708000-00029     Document Type: Article

References (40)

1. Offner F, Phillipe J, Vogelaers D, et al: Serum tumor necrosis factor levels in patients with infectious diseases and septic shock. J Lab Clin Med 1990; 16: 100-105
2. Marks JD, Marks CB, Luce JM, et al: Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 1990; 141:94-97
3. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17: 975-978
4. Dofferhoff As, Bom V, de Vries-Hospers HG, et al: Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor and acute phase proteins during treatment of severe sepsis in humans. Crit Care Med 1992; 20:185-192
5. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771-778
6. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103:565-575
7. Endo S, Inarda K, Inoue Y, et al: Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock 1992; 38:264-274
8. Hack CE, Hart M, Van Schijndel RJ, et al: Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infect Immun 1992; 60:2835-2842
9. Goode HF, Howdle BE, Walker BE, et al: Nitric oxide synthase activity is increased in patients with sepsis syndrome. Clin Sci 1995; 88:131-133
10. Cunha FQ, Moncada S, Liew FY: Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 1992; 182:1155-1159
11. McCall TB, Palmer RM, Moncada S: Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem Biophys Res Commun 1992; 186:680-685
12. Betz Corradin S, Fasel N, Buchmuller-Rouiller Y, et al: Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10. Eur J Immunol 1993; 23:2045-2048
13. Rosenkranz-Weiss P, Sessa WC, Milstien S, et al: Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 1994; 93: 2236-2243
14. Bailly S, Fay M, Roche Y, et al: Effects of quinolones on tumor necrosis factor production by human monocytes. Int J Immunopharmacol 1990; 12:31-36
15. Stunkel KGE, Hewlett G, Zeiler HJ: Ciprofloxacin enhances T cell function by modulating interleukin activities. Clin Exp Immunol 1991; 86:525-531
16. Riesbeck K, Forsgren A: Selective enhancement of synthesis of interleukin-2 in lymphocytes in the presence of ciprofloxacin. Eur J Clin Microbiol Infect Dis 1991; 9:409-413
17. Shalit I: Immunological aspects of new quinolones. Eur J Clin Microbiol Infect Dis 1991; 10:262-266
18. Roche Y, Fay M, Gougerot-Pocidalo MA: Effects of quinolones on interleukin-1 production by human monocytes. Immunopharmacol 1987; 13:99-109
19. Bailly S, Fay M, Ferrua B, et al: Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha. Clin Exp Immunol 1991; 85:331-334
20. Riesbeck K, Sigvardsson M, Leanderson T, et al: Superinduction of cytokine gene transcription by ciprofloxacin. J Immunol 1994; 153:343-352
21. Edgell CJS, McDonald CC, Graham JB: A permanent cell line expressing factor VIII related antigen established by hybridisation. Proc Natl Acad Sci U S A 1983; 80:3734-3737
22. Van Oost BA, Edgell CJS, Hay CW: Isolation of human von Willebrand factor cDNA from the EA.hy926 cell line. Biochem Cell Biol 1986; 95:355-360
23. Reiber AJ, Edgell CJS: Endothelium specific gene expression. Thromb Haemost 1989; 62:98
24. Edgell CJS, Haizlip JE, Bagnell CR, et al: Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell and Developmental Biology 1990; 26:1167-1172
25. 15N nitrate in biological fluids. Analytical Biochemistry 1982; 126:131-138
26. Schoedon G, Schneemann M, Blau N, et al: Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines. Biochem Biophys Res Commun 1993; 196:1343-1348
27. Gamble JR, Harlan JM, Klebanoff SJ, et al: Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci U S A 1985; 82:8667-8671
28. Gryglewski RJ, Dotting RM, Vane JR: Mediators produced by the endothelial cell. Hypertension 1988; 12:530-548
29. Cockerill GW, Meyer G, Nowack L, et al: Characterization of a spontaneously transformed human endothelial cell line. Lab Invest 1994; 71:497-509
30. Klein CL, Bittinger F, Kohler H, et al: Comparative studies on vascular endothelium in vitro. Pathobiology 1995; 63:83-92
31. Galley HF, Walker BE, Howdle PD, et al: Regulation of nitric oxide synthase activity in cultured human endothelial cells: Effect of antioxidants. Free Radic Biol Med 1996; 21:97-101
32. Werner-Felmayer J, Werner ER, Weiss G, et al: Modulation of nitric oxide synthase activity in intact cells by intracellular tetrahydrobiopterin levels. Adv Exp Med Biol 1993; 338:309-312
33. Barrett JF: The immunomodulatory activites of antibacterials. Expert Opinion in Investigational Drugs 1995; 4:551-557
34. Peng H-B, Libby P, Liao JK: Introduction and stabilization of IκBα by nitric oxide mediates inhibition of NFκB. J Biol Chem 1995; 270:14214-14219
35. Stadler J, Harbrecht BG, Di Silvio M, et al: Endogenous nitric oxide inhibits the synthesis of cyclo-oxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol 1993; 53:165-172
36. Andrew PJ, Harant H, Lindley IJD: Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem Biophys Res Commun 1995; 214:949-956
37. Villarete LH, Remick DG: Nitric oxide regulation of IL-8 expression in human endothelial cells. Biochem Biophys Res Commun 1995; 211:671-676
38. Barthlen W, Stadler J, Lehn NL, et al: Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor alpha and negatively with body temperature in patients with postoperative abdominal sepsis. Shock 1994; 2:398-401
39. Galley HF, Webster NR: Plasma nitrite is increased in patients who die from sepsis. Abstr. Intensive Care Med 1996; 22(Suppl 3):S327
40. Gennari R, Alexander WA: Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time dependent manner by enhancing host defence. Crit Care Med 1995; 23:1945-1953